Effect of Dotinurad on Serum Uric Acid Concentration in Chronic Kidney Disease Patients Treated with Febuxostat
This study is the first to show the effect of combining dotinurad with febuxostat in lowering sUA levels in G3 and G4 patients. Additional research is required in order to clarify the pharmacological mechanisms of dotinurad in patients with CKD.
Authors
- Osamu Kurihara (ORCID: https://orcid.org/0000-0002-6362-6188)
- Yukinao Sakai (ORCID: https://orcid.org/0000-0002-8558-0571)
- Masato Iwabu
- Takehisa Yamada (ORCID: https://orcid.org/0000-0001-9474-1341)
- Tetsuya Kashiwagi (ORCID: https://orcid.org/0000-0001-8942-5512)
Institutions
- Chiba Hokusou Hospital (JP)
- Nippon Medical School (JP)
Publication Details
- Journal
- Journal of Nippon Medical School
- Published
- 2024-08-25
- DOI
- https://doi.org/10.1272/jnms.jnms.2024_91-403
- Citations
- 2
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 0.68